The 12-month open-label extension of the PACIFIC trial demonstrated that bexicaserin significantly reduced seizure frequency ...

Our grey matter has always been a mystery, even to neurologists, but Professor Masud Husain says life-changing advances may ...

Heavy lifetime cannabis use is associated with reduced brain activation in key cognitive regions, particularly during working ...

L ong-term heavy cannabis use could have a detrimental effect on an aspect of cognition called working memory, according to ...

A pathway once considered fundamental in Alzheimer’s disease is being studied intensely again, and may soon result in safer, ...

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new sophistication. The management of chronic pain in general is now being broadly ...

Bexicaserin achieved an overall median seizure reduction of 59.3 percent in countable motor seizures over a 12-month open-label extension (OLE) treatment period. The treatment with bexicaserin ...

February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart ...

A new international study has unveiled critical insights in understanding post-traumatic epilepsy (PTE), a condition that can develop following traumatic brain injury.

What was of particular interest (in relation to the recovery of John Famechon) was the process of discovering what was ...

In a significant advancement for Parkinson’s Disease (PD) therapy, researchers have developed a targeted nano formulation ...